Immunomodulated anterior chemotherapy followed by concurrent chemoradiotherapy in locally advanced tongue cancer: An Institutional experience.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4363850)

Published in Indian J Med Paediatr Oncol on March 26, 2015

Authors

Bappaditya Chhatui1, Devleena1, Sanjoy Roy1, Tapas Maji1, Debarshi Lahiri1, Jaydip Biswas1

Author Affiliations

1: Department of Radiotherapy, Chittaranjan National Cancer Institute, Kolkata, West Bengal, India.

Articles cited by this

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med (2007) 10.06

Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res (1988) 7.30

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol (2003) 6.82

Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst (1994) 2.83

Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol (2005) 2.66

Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol (2000) 2.45

Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy. J Clin Oncol (2004) 2.29

Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tête et du Cou (GETTEC). Br J Cancer (2000) 1.84

Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin. Cancer (1985) 1.56

Oral cancer: necessity for prevention strategies. Lancet (1993) 1.46

Alcohol, tobacco, diet and the risk of oral cancer: a pooled analysis of three case-control studies. Eur J Cancer B Oral Oncol (1995) 1.30

End points for new agents in induction chemotherapy for locally advanced head and neck cancers. Ann Oncol (2002) 1.16

Combined modality therapy of head and neck cancer. Semin Oncol (1994) 1.12

Phase 2 bioadjuvant study of interferon alfa-2a, isotretinoin, and vitamin E in locally advanced squamous cell carcinoma of the head and neck: long-term follow-up. Arch Otolaryngol Head Neck Surg (2005) 0.87

Intensive recombinant interleukin-2 and alpha-interferon therapy in patients with advanced head and neck squamous carcinoma. Cancer (1993) 0.86

Neoadjuvant chemotherapy of cisplatin and fluorouracil regimen in head and neck squamous cell carcinoma: a meta-analysis. Chin Med J (Engl) (2008) 0.85